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Abstract
In skeletal muscle, the excitation-contraction (EC) coupling machinery mediates the translation of the action
potential transmitted by the nerve into intracellular calcium release and muscle contraction. EC coupling requires a
highly specialized membranous structure, the triad, composed of a central T-tubule surrounded by two terminal
cisternae from the sarcoplasmic reticulum. While several proteins located on these structures have been identified,
mechanisms governing T-tubule biogenesis and triad formation remain largely unknown. Here, we provide a
description of triad structure and plasticity and review the role of proteins that have been linked to T-tubule
biogenesis and triad formation and/or maintenance specifically in skeletal muscle: caveolin 3, amphiphysin 2,
dysferlin, mitsugumins, junctophilins, myotubularin, ryanodine receptor, and dihydhropyridine Receptor. The
importance of these proteins in triad biogenesis and subsequently in muscle contraction is sustained by studies on
animal models and by the direct implication of most of these proteins in human myopathies.
Introduction
To trigger skeletal muscle contraction, the action poten-
tial generated by motor neurons is transmitted through
motor nerves to muscle cells. The excitation-contraction
(EC) coupling, i.e. signal transmission from the sarco-
lemma to the actin/myosin apparatus, is mediated by a
second messenger, calcium ions. Indeed, muscle fibers
contain large internal calcium stores with the ability to
quickly release and retrieve calcium (Figure 1, right
panel). For a fast and fine-tuning of muscle contraction,
these stores are maintained under the control of the
action potential, which ensures calcium release simulta-
neously within the whole interior of the muscle fiber. As
myofibers are 50-100 μm in diameter and several milli-
meters to centimeters long, a highly specialized struc-
ture named the triad is necessary to overcome spatial
limits in using calcium as secondary messenger, and
connect the sarcolemma with the calcium stores. The
sarcolemma forms regular invaginations which insert
between myofibrils, termed transverse tubules (T-
tubules). In skeletal muscle, T-tubules tightly associate
with the sarcoplasmic reticulum (SR), in a region called
terminal cisternae/junctional SR. The close association
of one T-tubule with two terminal cisternae on both
sides of the tubule forms the triad (Figure 1).
A large set of specialized proteins takes part in EC
coupling and includes: i) the Dihydhropyridine Receptor
(DHPR), a voltage gated calcium channel located on T-
tubule membranes [1,2], ii) the Ryanodine Receptor
(RyR1), a calcium release channel that is localized on
the junctional face of SR and appears as “feet” when
observed by electron microscopy (Figure 1, left panel)
[3], iii) calcium buffering proteins such as calsequestrin
in the lumen of the SR [4], iv) calcium channel regula-
tors such as calmodulin, FKBP12 and many others [5,6],
v) Sarco-Endoplasmic Reticulum Calcium ATPase
pumps (SERCA), which is indirectly involved in EC cou-
pling via its action in the rapid removal of the cytosolic
calcium after fiber shortening to replenish the calcium
stores [7]. Noteworthy, the physical coupling between
RyR1 and DHPR occurs specifically in skeletal but not
in cardiac muscles and allows the transmission of the
signal within 2 ms in skeletal muscles compared to 100
ms in cardiac muscles [8]. In cardiac myofiber, RyR2-
mediated calcium release is induced by extracellular
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calcium entry via DHPR in a mechanism called calcium-
induced calcium release (CICR) [8]. Moreover, in fibers
of small diameter, such as the body muscles of
Amphioxus, peripheral couplings between SR and the
plasmalemma have similar function to triads. In addi-
tion, all differentiating muscle fibers pass through a
stage where T-tubules are not present and EC coupling
is mediated by such peripheral couplings.
In this review, we will focus on the molecular
mechanisms underlying T-tubules biogenesis and triad
formation specifically in skeletal muscle. Triad defects
linked to human monogenic diseases will also be
highlighted.
T-tubule plasticity
The T-tubule membrane possesses a high plasticity
which provides the stability required during muscle con-
traction, and facilitates repair upon damage. In addition
to its principal function in EC coupling, the plasticity of
T-tubules confers to this system non-related EC
functions.
It has been reported that the treatment of isolated
muscle fibers with glycerol efflux-influx or with other
low molecular weight nonelectrolytes (such as sugars)
physically affects T-tubules morphology. Such osmotic
shock can convert the T-tubule network into many
membrane-bound vacuoles, which can either remain
interconnected by normal T-tubules, or become sepa-
rated (Figure 2) [9,10]. Surprisingly, this vacuolation
which results in 5-15 fold increase in the relative
volume of T-tubule system is reversed spontaneously
[11,12]. Moreover, this observation is specific to trans-
verse tubule membranes, as no other intracellular mem-
brane systems appear to be involved [12], probably due
to the fact that their lumen connects to the extracellular
space.
In addition to this artificial condition, this vacuolation
phenomenon is observed upon muscle fatigue or dis-
eases [10,13]. Based on this plasticity and on the large
membrane surface of the T-tubules network which cor-
responds to about 80% of the sarcolemma surface, sev-
eral functions non-related to EC coupling are proposed
for the T-tubules system [10,13]. These include: i) water
balance and regulation of cell volume, ii) recovery from
muscle fatigue, iii) transport pathways including endocy-
tosis, exocytosis and the penetration of foreign DNA.
The molecular mechanisms involved in these processes
are still to be investigated.
Morphological aspects of triad biogenesis
Sarcoplasmic reticulum
The SR represents the main calcium store in striated
muscle. It is highly specialized to ensure the simulta-
neous release of intracellular calcium in the entire cyto-
sol of the muscle cell. The first step of SR biogenesis
starts by the formation of tubular endoplasmic reticu-
lum (ER) (30-60 nm in diameter) adjacent to the myofi-
bril [14]. Subsequently, these tubular branches of ER
Figure 1 Triad organization in skeletal muscle. Left: Electron micrograph of a triad junction. A central T-tubule is flanked on both sides by a
terminal cisternae element from the sarcoplasmic reticulum. Arrows indicate electron-dense junctional feet corresponding to the ryanodine
receptor-dihydhropyridine receptor complex. Right: Schematic representation of a mammalian muscle sarcomere and surrounding membranes.
T-tubules shown in gray are specialized invaginations of the sarcolemma. The elaborated sarcoplasmic reticulum network is shown in blue. Note
the close proximity of T-tubules and terminal cisternae of the sarcoplasmic reticulum (adapted from [104]; © 2007 by Pearson Education, Inc.).
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develop into reticular structures surrounding the myofi-
brils [15]. Finally, the newly formed SR engages cou-
plings at the A-I interface with the T-tubule originating
from the sarcolemma. The molecular determinants
implicated in the functional and structural organization
of the SR have been reviewed elsewhere [16].
The chronology of SR biogenesis was well investigated
using electron microscopy (EM) during muscle differen-
tiation in mouse [17]. These observations were also sup-
ported by studies employing chicken embryo [18]. In
mouse, the SR is detected from as early as embryonic
day 14 (E14) with punctate RyR clusters that are located
in the periphery of the myofiber [17]. At this stage, the
content of the feet (RyR) in the junctional SR is poor,
and some SR elements without any feet are observed. At
E16, RyR containing elements become abundant and
start to be associated with the edges of A bands (A-I
junctions) of the newly formed sarcomeres. This associa-
tion results in a distinct banding pattern of a discrete SR
network at the I-band with thin longitudinal connecting
SR elements [17]. During the next days (E17 and E18),
junctional SR acquires a predominant transverse distri-
bution taking their final position by forming triad rows
at each side of the Z-line (two SR sacs connecting one
T-tubule in each triad) [17]. During the maturation of
SR membranes, the frequency of feet increases, in
particular, between E16 and E18, when all junctions
become filled by feet. The width of the junctional gap is
between 9 and 12 nm. The maturation of the RyR con-
taining elements is accomplished at birth [17]. Elegant
experiments using tagged SR proteins in differentiating
myotubes showed that the SR organization was paral-
leled by a dynamic localization of longitudinal and junc-
tional SR proteins [19].
Transverse tubule
T-tubules are invaginations of the plasma membrane,
which are present exclusively in striated muscle. Their
role is to maintain the SR calcium store under the tight
control of membrane depolarization via the voltage sen-
sor channel DHPR [2]. Morphological studies in chicken
and mouse embryos have revealed that the T-tubules
start their formation after the SR [17,18]. In mouse
embryos, the first defined tubules can be observed at
E15. At this stage they take the aspect of short cylinders
invaginating from the sarcolemma within the myotubes
[17]. At E16, the newly formed T-tubules extend deeper
within the myofiber, maintaining a connection with the
surface by short transverse segments however they stay
predominantly longitudinal. During the last days of
gestation (E17, 18, 19), T-tubules progressively invade
the entire fiber; the majority of them are longitudinal
with some transverse connecting elements [17,18]. The
Figure 2 Dynamics of T-tubule vacuolation produced by the efflux of glycerol. A single frog skeletal muscle fiber stained with a lipophilic
fluorescence probe is shown. Shown are serial confocal microscopic images of the same fiber (a) 5 minutes, (b) 12 minutes and (c) 30 minutes
after the fiber was transferred from a solution containing 110 mM glycerol to a solution without glycerol (reprinted from [10]; © 2001 with
permission from Elsevier).
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transverse orientation of T-tubules is achieved during
the postnatal period. Final maturation of T-tubules is
completed in mouse 3 weeks after birth [17,20].
Molecular mechanisms involved in T-tubule biogenesis
and triad formation and maintenance
Although the events characterizing T-tubule biogenesis
and triad formation are morphologically defined, mole-
cular mechanisms remain elusive. In the last 20 years,
several proteins were proposed to be involved in these
mechanisms, and mutations within most of the corre-
sponding genes are associated to muscular disorders in
human and/or in rodents. These proteins include caveo-
lin 3 (CAV3), the skeletal muscle specific isoform of
amphiphysin 2 (BIN1), dysferlin (DYSF), mitsugumins
(MG), junctophilin (JPH1), and myotubularin (MTM1)
(Table 1). In this context, one should distinguish
between mechanisms leading to T-tubule biogenesis and
those involved in the proper assembling of triad compo-
nents (i.e. one T-tubule element with two junctional SR
cisternae). Based on previous reports, we classified
CAV3, BIN1, DYSF in T-tubule biogenesis, and mitsu-
gumins and junctophilin in triad formation, while the
position of MTM1 in this classification is still unclear.
Caveolin 3
Caveolae are subcompartments of the plasma membrane
which take the aspect of 50-100 nm vesicular invagina-
tions, and have an important role in signal transduction
and vesicular transport [21]. In contrast to the other
plasma membrane regions which are composed mainly
of phospholipids, caveolae are considered as cholesterol-
sphingolipid rich raft domains [22]. The principal pro-
tein components of the caveolae are the caveolins
(CAV), which are cholesterol-binding proteins [22]. The
caveolin family is represented in mammals by three
members; both CAV1 and CAV2 are co-expressed in
non-muscle cells especially adipocytes [21,23] whereas
CAV3 is found essentially in striated muscles, and its
expression is induced during muscle differentiation [24].
In skeletal muscle, CAV3 localizes at the sarcolemma
where it can form a complex with dystrophin and its
associated glycoproteins [25]. In addition to the sarco-
lemma, CAV3 is localized to the developing T-tubules
[26].
Mutations within CAV3 are associated with several
muscular disorders. In particular, mutations which lead
to loss of the CAV3 protein, or a decrease of more than
90% of CAV3 expression, result in autosomal dominant
limb-girdle muscular dystrophy (LGMD1C), manifesting
by mild to moderate proximal muscle weakness [27]. In
addition, CAV3 is found mutated in rippling muscle dis-
ease [28], familial hypertrophic cardiomyopathy [29] and
long QT syndrome 9 [30]. Moreover, its expression is
increased in tibialis anterior from the mdx mouse, sug-
gesting that CAV3 may contribute to the pathogenesis
of DMD [31].
Mice lacking CAV3 display a mild myopathic pheno-
type similar to the human pathology [32]. Besides, the
ectopic expression of CAV3 in mice leads to Duchenne-
like muscular dystrophic phenotype [33]. According to
its localization at T-tubules, CAV3 deletion leads to dis-
organization of T-tubule membranes which become
dilated and lose their transverse orientation (Figure 3a
and 3b) [32]. This provides evidence that CAV3 is cru-
cial for muscle function and has a role in T-tubules bio-
genesis. Several evidences lead to the hypothesis that
similar mechanisms control the formation of the T-
tubule system and the caveolae. Indeed, the mature and
the developing T-tubules are associated with CAV3 and
contain approximately four times more cholesterol than
the plasma membrane [34,35]. Moreover, treatment of
epithelial cells with Amphotericin B, a cholesterol-bind-
ing drug, results in a loss of morphologically defined
caveolae at the cell surface. Similarly to CAV1 in epithe-
lial cells, DHPR a and CAV3 are dramatically redistrib-
uted after Amphotericin B treatment of C2C12
Table 1 Proteins implicated in triad organization, roles and associated human diseasesa
Phenotype in humans Phenotype in rodents
Proteins Skeletal
muscle
Cardiac
muscle
Skeletal
muscle
Cardiac
muscle
Membrane binding Membrane events Associated human
diseases
CAV3 Yes Yes Yes Yes Cholesterol binding Caveolae formation LGMD-1C, RMD, FHC,
LQTS
BIN1 Yes Yes n.r. Yes Phosphoinositide binding Membrane tubulation ARCNM
DYSF Yes Yes Yes Yes Transmembrane/
phospholipid binding
Membrane repair Dysferlinopathies
MG29 n.r. n.r. Yes No Transmembrane binding Triad structure n.r.
JPH1 n.r. n.r. Yes No Phospholipid binding Sarcolemma and SR junction
formation
n.r.
MTM1 Yes No Yes No Phosphoinositide binding Membrane transport XLMTM (XLCNM)
an.r., not reported; LGMD-1C, limb-girdle muscular dystrophy type 1C; RMD, rippling muscle disease; FHC, familial hypertrophic cardiomyopathy; LQTS, long-QT
syndrome; ARCNM, autosomal recessive centronuclear myopathy; SR, sarcoplasmic reticulum; XLMTM, X-linked myotubular myopathy; XLCNM, X-linked
centronuclear myopathy.
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myotubes. Interestingly, other cholesterol-rich compart-
ments such as the trans-Golgi network do not seem
affected [34].
Amphiphysin 2 (BIN1)
Mutations in BIN1 are associated to the autosomal
recessive form of centronuclear myopathy [36], a disease
characterized by muscle weakness, myofiber atrophy,
and abnormal positioning of nuclei within muscle fibers.
Amphiphysins are membrane bending and curvature
sensing proteins able to tubulate lipid membranes via
their BAR (Bin/Amphiphysin/Rvs) domain. The ubiqui-
tous amphiphysin 2, encoded by the BIN1 gene, is
highly expressed in skeletal muscle and is proposed to
participate in T-tubule biogenesis. Its role in this pro-
cess is provided by a polybasic amino-acid stretch
encoded by exon 11, which is important for its recruit-
ment to T-tubule membranes [37,38]. This polybasic
sequence can bind specifically the phosphoinositides
PtdIns(4,5)P2 and PtdIns4P in vitro. Interestingly, the
levels of PtdIns(4,5)P2 and BIN1 increase simultaneously
during C2C12 myotubes differentiation [37,39].
In addition, BIN1 can tubulate membranes separately
or in cooperation with dynamin 2 (DNM2), another
protein mutated in centronuclear myopathy [40,41]. The
cooperation between BIN1 and DNM2 is mediated by
the interaction of BIN1 SH3 domain with the proline
rich domain of DNM2. However, this interaction may
not occur prior to BIN1 association to membranes, as
the polybasic sequence binds to the SH3 domain when
it is not membrane bound [42]. Indeed, PtdIns(4,5)P2
binding is necessary to release the SH3 domain, further
enabling the interaction between the SH3 domain and
DNM2 [42]. While the existence of this intramolecular
regulation has been deciphered in cultured cells, it is
Figure 3 Proteins implicated in triad organization in skeletal muscle. (a) Electron microscopic image showing ferrocyanate-treated muscle
from wild-type mouse. (b) Electron microscopic image showing ferrocyanate-treated muscle from Cav3 (caveolin 3)-mutant mouse. Note the
altered appearance and orientation of T-tubules (from [32]; © 2001 The American Society for Biochemistry and Molecular Biology). (c) Electron
microscopic image from Drosophila normal muscle. Note that dyads are localized in proximity to the Z-line (similar to vertebrate). (d through f)
Electron microscopic images from Bin1 (amphiphysin)-null Drosophila showing alteration of T-tubules resulting in (d) mislocalized, (e)
longitudinal and (f) dilated tubules (from [43]; © 2001 Cold Spring Harbor Laboatory Press). (g through j) Electron microscopic images of
ferrocyanate-treated muscles from (g and h) wild-type and (i and j) MG29 (mitsugumin)-knockout mice demonstrating the alterations in T-
tubule organization. Note the absence of (i) T-tubule or (j) longitudinal orientation (from [61]; © 1999 The Rockefeller University Press. The
Journal of Cell Biology, 2002, 159:695-705). (k and l) Electron microscopic images from (k) wild-type and (l) JPH1 (junctophilin)-knockout skeletal
muscles from neonate mice showing the altered triads with swollen SR (reprinted from [73]; © 2002 with permission from Elsevier). (m and n)
Electron microscopic images of ferrocyanate-treated muscles from (m) wild-type and (n) Dysf (dysferlin)-knockout mice showing an abnormal
shape of the T-tubule system (from [51]; © 2010 John Wiley and Sons). (o and p) Electron microscopic images of ferrocyanate-treated muscles
from (o) wild-type and (p) Mtm1 (myotubularin)-knockout mice revealing a severe alteration in T-tubule organization. Note the absence
(arrowhead) or the longitudinally oriented (arrow) T-tubules (from [82]; © 2009 National Academy of Sciences, USA).
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not determined whether a similar mechanism regulates
T-tubules curvature. Nevertheless, myotubes expressing
a BIN1 mutant lacking the polybasic sequence failed to
form a normal membrane tubules network [42].
A drosophila mutant lacking the orthologue of BIN1
(amphiphysin) exhibits a skeletal muscle defect asso-
ciated to alterations in T-tubule morphology and EC
coupling (Figure 3c-f) [43]. Interestingly, EM analysis of
muscle biopsies from patients with BIN1 mutations
revealed abnormal morphology of T-tubules [44]. In cul-
tured COS-1 cells, overexpression of a mutation related
to CNM in the BAR domain failed to form membrane
tubules compared to the wild-type construct, suggesting
that the lack of BIN1-mediated membrane remodeling
could be at the basis of the muscle disease [36].
Surprisingly, no skeletal muscle defect was reported in
Bin1 -/- mice. However, these mice are dying perinatally
due to cardiomyopathy, precluding a detailed analysis of
skeletal muscle after birth [45].
Dysferlin
Dysferlin (DYSF) is a 230 kDa protein belonging to a
family of genes similar to Caenorhabditis elegans ferlin.
It contains a C-terminal transmembrane domain and
multiple C2 domains implicated in calcium binding and
calcium-dependent membrane fusion and repair. Muta-
tions within the DYSF gene are associated with allelic
muscular disorders including autosomal recessive limb-
girdle muscular dystrophy type 2B [46], Miyoshi myopa-
thy [47], and distal anterior compartment myopathy
[48]. DYSF has a sarcolemmal localization in differen-
tiated skeletal muscle, which is related to its role in
membrane repair [49]. However, studies performed in
C2C12 cells have shown that during myotubes differen-
tiation, DYSF is associated to the T-tubules network in
addition to sites of cells fusion, and can translocate to
the sarcolemma upon myofiber injury [50]. Interestingly,
studies performed in adult rat muscles, in which regen-
eration was induced by subcutaneous injection of
notexin, have revealed that during early stage of muscle
fiber regeneration (within the first week after notexin
treatment), DYSF is mainly localized to T-tubules and
translocates toward the sarcolemma in later stages of
regeneration [51].
Several mouse lines have been generated to manipu-
late the level and the function of DYSF, and the sponta-
neous SJL strain was shown to encompass an in-frame
deletion in the C-terminal of the Dysf gene [49,52-55].
Similarly to CAV3 mouse mutants, mice deficient for
DYSF display alterations in T-tubule structure, with
more dilated and longitudinally oriented tubules [51]
(Figure 3m-n). These defects are considered as primary,
as they are observed at early stage of the disease when
abnormalities in the myofibrillar architecture and the
sarcolemma are minimal. The role of DYSF in T-tubule
biogenesis is still not determined, however, it has been
suggested that DYSF contributes to the fusion of caveo-
lin 3 containing vesicles with T-tubules. This suggestion
is based on i) the interaction of DYSF with DHPR in
mature skeletal muscle, ii) the known interaction
between DYSF and CAV3, and iii) the partial co-locali-
zation between CAV3 and DYSF during early myogen-
esis [56,57]. This hypothesis is also supported by the
accumulation of subsarcolemmal vacuoles contiguous
with the T-tubule system in dysferlinopathy patients
[58].
Mitsugumins
In addition to the proteins mentioned above, which are
involved in the biogenesis of T-tubules, other proteins
are implicated in the maturation of SR terminal cister-
nae, and the junction between T-tubules and SR. This is
the case of members of the Synaptophysin family such
as mitsugumin 29 (MG29 or synaptophysin-like 2,
SYPL2), a transmembrane proteins highly enriched in
heavy SR vesicles preparation [59]. MG29 is expressed
early during myogenesis, even before the apparition of
triads. It first associates to newly formed SR vesicles and
then to triads, which appear later during myogenesis
[59]. These observations implicate MG29 in the early
formation of junctional SR and its connection to T-
tubules [59,60]. In MG29-KO mice, decreased muscle
mass and a slight decrease in the force generation capa-
city were observed [61]. Dysfunction of store-operated
calcium entry (SOCE) leading to defects in intracellular
calcium homeostasis, and increased muscle fatigability
were also reported in these mice [62,63]. EM analysis of
mutant muscles revealed morphological alterations in
triad structures, including a swollen SR and longitudinal
T-tubules (Figure 3g-j) [61]. However, the actual asso-
ciation between SR and T-tubules does not appear
altered. It thus remains unclear whether such disorders
in the triad structure have a link with the observed
defect in SOCE.
Another mitsugumin, MG53 (also called TRIM72), has
been identified as a key player in intracellular membrane
trafficking and membrane repair machinery in striated
muscles [64,65]. In addition to it specific expression in
striated muscles, MG53 was shown to bind to dysferlin
and caveolin 3, two proteins directly implicated in T-
tubule biogenesis [64,66]. There are no studies demon-
strating a direct implication of MG53 in the biogenesis
of triad membranes; however, the current evidences sus-
tain its implication as a potential new partner in this
mechanism.
Junctophilins
JPH family members are identified as components of
junctional membranes, where they may bridge the SR
via their C-terminal transmembrane domain, with the
T-tubule/plasma membrane via their N-terminal
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domain. More specifically, the N-terminal domain can
bind to membrane phospholipids including sphingomye-
lin and phosphatidylcholine [67]. Among the four junc-
tophilin-like proteins in mammals (JPH1-4), JPH1 is
expressed mainly in skeletal muscle while JPH2 is also
expressed in cardiac muscle and implicated in hyper-
trophic cardiomyopathies [67-69]. However, JPH3 and 4
are coexpressed in brain where JPH3 is found to be
associated to a Huntington-like disease [70,71].
JPH1 deficient mice die shortly after birth due to
defects in jaw muscles resulting in lack of milk suckling
[72]. Electron microscopy analysis of skeletal muscle
from embryos and newborn mice revealed several
abnormalities in triad morphology, leading to defect in
muscle contraction [72,73]. These anomalies include a
reduced number of triads, swollen junctional SR, par-
tially vacuolated longitudinal SR and irregular orienta-
tion of SR network (Figure 3k-l). Moreover, functional
analysis of mutant muscles from neonate mice revealed
that these muscles have an increased response to extra-
cellular calcium stimuli, indicating a defect in EC cou-
pling [72]. A specific role of JPH1 in the biogenesis of
membrane junctions is also supported by its ability to
induce junctions between the endoplasmic reticulum
and the plasma membrane when overexpressed in
amphibian embryonic cells [67]. In addition, the expres-
sion of JPH1 is enhanced after birth as an indicator of a
role in the late biogenesis and maturation of triads [72].
Myotubularin
Myotubularin (MTM1) is part of a family of phosphoi-
nositides phosphatases conserved through evolution
down to yeast, and with 14 members in human [74].
While myotubularin is ubiquitously expressed, muta-
tions within MTM1 lead to a skeletal muscle disorder:
the X-linked form of centronuclear myopathy, also
called myotubular myopathy, associating severe muscle
atrophy and weakness at birth with abnormal position-
ing of nuclei [75]. This indicates that MTM1 has a mus-
cle-specific role, which cannot be compensated by
homologous proteins. In vitro and overexpression stu-
dies performed in yeast and mammalian cells have
attributed to MTM1 a function in endosomal and mem-
brane trafficking pathways and have shown that MTM1
specifically dephosphorylates PtdIns3P and PtdInsp(3,5)
P2 into phosphatidylinositol and PtdIns5P respectively
[76-79]. Recently, immunohistology and EM analysis
revealed that AAV mediated overexpression of MTM1
in mouse muscle results in the formation of abnormal
membrane structures [80]. These structures include
vacuoles that are derived from sarcolemma and/or T-
tubules, as they have positive staining for caveolin-3,
dystrophin and dihydropyridine receptor (DHPR), and
negative staining for laminin 2, and also contain the
exogenous MTM1 protein [80]. This indicates a direct
or indirect role for MTM1 in the generation or mainte-
nance of membrane structures in skeletal muscle.
Mtm1 KO mice exhibit a progressive centronuclear
myopathy [81]. EM analysis of Mtm1 KO muscles
revealed alterations in T-tubules structure characterized
by longitudinal orientation of T-tubules and the pre-
sence of triads deprived from T-tubule components
(Figure 3o-p) [82]. These alterations become more pro-
nounced with disease progression [44,82]. Similarly,
mtm1 zebrafish morphants and mtm-depleted droso-
phila muscles display structural defects of the triads,
and such defects have been also observed in muscles
from patients with myotubular myopathy [44,83,84].
Since MTM1 expression is increased in the postnatal
life in mouse and Mtm1 KO muscles display less altered
T-tubules at an early stage than at a late stage of the
disease, it is likely that MTM1 plays a key role in the
late maturation and/or the maintenance of T-tubules
rather than in their early biogenesis.
The RyR-DHPR complex
The RyR-DHPR interaction is physically linking the SR
to T-tubules in skeletal muscle, and thus mediates the
translation of the action potential into intracellular cal-
cium release. RyR1, the skeletal muscle ryanodine recep-
tor, is implicated in the susceptibility to malignant
hyperthermia [85,86], and mutated in myopathies with
variable histological outcomes as central core [87,88],
multi-minicore [89], congenital fiber type disproportion
[90,91], and/or nuclei centralization [92,93]. It was
thought that the direct interaction between RyR and
DHPR is necessary for T-tubule and SR assembly [94].
The concomitant expression of RyR and DHPR during
myogenesis is consistent with this idea [94]. However, it
has been shown by immunofluorescence and EM studies
performed in mouse models lacking one or both pro-
teins that it is unlikely to be the case. More specifically,
mutant mice lacking RyR (dyspedic) or DHPR (muscular
dysgenesis, mdg mouse), or even both proteins form
triadic junctions with a similar architecture than wild-
type mice [95-99]. Moreover, these myotubes have a
normal disposition of other SR components such as cal-
sequestrin and triadin, although calcium release from
intracellular stores is greatly affected [96,100]. This indi-
cates that neither RyR nor DHPR are necessary for the
biogenesis of the triad structure.
In addition, the targeting of DHPR and RyR to their
respective membrane is independent of each other
[18,99]. This suggests that the T-tubule and SR sepa-
rately posses the potential for self-assembly.
Conclusion
Whether T-tubule origin is from an inward or outward
movement of membranes has been debated for many
decades. Some co-workers have suggested that caveolar
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invagination fuses with the internal membrane tubules
and thus facilitates their connection to the surface [34].
However, increasing evidences support the hypothesis
that T-tubules are formed by surface membrane invagi-
nations starting from caveolae [17,18,37]. During myofi-
ber maturation, the T-tubule network grows up to
occupy the entire muscle fiber. It is likely that T-tubule
proliferation happens by two complementary mechan-
isms: 1) membrane invagination and tubulation, and 2)
membrane addition (Figure 4). BIN1 is a promising can-
didate for the regulation of membrane tubulation at T-
tubules. Invagination of T-tubules may be triggered at
the site of caveolae formation on the sarcolemma. It is
also possible that the growth of T-tubules is ensured by
new membranes derived from endosomes and/or caveo-
lae. CAV3, DYSF and MTM1 may play a major role in
the formation and remodeling of growing T-tubules by
regulating the incorporation of internal membranes and/
or the turnover of existing tubular membranes. On the
SR side, mitsugumin and junctophilin proteins would be
important for the positioning of junctional SR to the
proximity of transversal tubules. Membrane invagination
and tubulation might be more active during early stages
of T-tubule biogenesis (i.e. during muscle differentiation
or after muscle injury), and membrane addition may be
the main mechanism for T-tubule proliferation during
postnatal muscle growth or maintenance.
It is likely that other proteins may have important
roles in these processes, like triadin [19,101,102], a pro-
tein located on the SR, or telethonin (TCAP)) a large
protein implicated in sarcomere assembly and recently
suggested to play a role in T-tubule biogenesis [103],
although their direct impact in triad biogenesis in skele-
tal muscle remains to be confirmed. There is still a lot
Junctional T-tubule
CAV3
BIN1
MG29
sarcoplasmic
reticulumJPH1
DYSF
MTM1
DHPR
RYR1
Figure 4 Hypothetical model for triad biogenesis in skeletal muscle. The different proteins discussed in the section Molecular mechanisms
involved in T-tubule biogenesis and triad formation and maintenance are indicated, and their hypothetical implications in T-tubule biogenesis
and triad formation and maintenance are depicted. Details can be found in the conclusion section.
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to learn about other potential proteins involved in triad
biogenesis and to understand their biological role in
muscle development.
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